In EAM, our results replicate a previously reported finding that the CTBP2 rs4962416 confers increased PCa risk: OR = 1.69, P = 0.0415 in our study versus the overall GWAS data: OR = 1.25, P = 0.004 [25]. The gene discussed is CTBP2; the disease is posterior cortical atrophy.